ENTRADA THERAPEUTICS, INC. (TRDA) Return on equity 2023–2025
ENTRADA THERAPEUTICS, INC. (TRDA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-47.0%FY2025 · since FY2023: -2.8% → -47.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -47.0% | -62.3 pp |
| FY2024 | 15.3% | +18.1 pp |
| FY2023 | -2.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TRDA financial trends
TRDA RevenueTRDA Net incomeTRDA Net marginTRDA Gross profitTRDA Gross marginTRDA Operating incomeTRDA Operating marginTRDA Operating cash flowTRDA Free cash flowTRDA Capital expendituresTRDA Stock buybacksTRDA Dividends paidTRDA Total assetsTRDA Total liabilitiesTRDA Shareholders’ equityTRDA overview →